Delving into the Latest Updates on Beijing Tongyu Kangtai Technology Co., Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Cardiovascular Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Herbal medicine	1

To preliminarily evaluate the therapeutic effect and symptom improvement of Zhilong Tongluo Tablets in early application for cerebral infarction (Qi deficiency and blood stasis syndrome in the meridian-recovery period of stroke), conduct dose exploration, and observe the safety of Zhilong Tongluo Tablets in clinical application.

Start Date26 Jan 2015

Sponsor / Collaborator

Beijing Tongyu Kangtai Technology Co., Ltd.

100 Clinical Results associated with Beijing Tongyu Kangtai Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Beijing Tongyu Kangtai Technology Co., Ltd.

Login to view more data

100 Deals associated with Beijing Tongyu Kangtai Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Tongyu Kangtai Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data